Physician profile
Pradhum Ram
NPI 1194108373
$2,988.37
in general payments reported to CMS, 2019-2025
8 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $204 · 2022: $2,063 · 2023: $86.86 · 2024: $180 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,109.73 | 2021-2022 | |
| Boston Scientific Corporation | $300.84 | 2024-2025 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Cardiva Medical, INC. | $157.45 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $143.52 | 2025 | Camzyos |
| Medtronic, INC. | $103.32 | 2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $76.62 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.52 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $39.37 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradhum Ram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.